Supplementary Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability

Amy Dawson (3050073); Anne M. Haegert (14931942); Brian McConeghy (6374561); Cheng-Han Lee (258779); Colin C. Collins (7951469); Gabriel E. DiMattia (14949711); Gregg B. Morin (14945233); Hannah Kim (358726); Joshua Hoenisch (6187673); Mark S. Carey (14949714); Marta Llaurado Fernandez (14949696); Nelson K.Y. Wong (14949705); Raunak Shrestha (14949693); Robert H. Bell (14949708); Shane Colborne (6037397); Shawn Anderson (623199); Sonal Brahmbhatt (600645); Stanislav Volik (14949699); Stephane Le Bihan (6279083); Yen-Yi Lin (14949702)

journal article text

Supplementary Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability

Abstract

Supplementary Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerabilit

Similar works

Full text

Available Versions

The Francis Crick Institute

oai:figshare.com:article/22428...

Last time updated on 02/04/2023